These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27540834)

  • 1. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
    Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
    Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
    Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
    Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
    Najar HM; Dutz JP
    J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
    J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma.
    Kiyohara E; Tamai K; Katayama I; Kaneda Y
    Gene Ther; 2012 Jul; 19(7):734-41. PubMed ID: 21900962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
    Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
    Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression.
    Faião-Flores F; Quincoces Suarez JA; Fruet AC; Maria-Engler SS; Pardi PC; Maria DA
    PLoS One; 2015; 10(3):e0118702. PubMed ID: 25742310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
    Gowda R; Sharma A; Robertson GP
    Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis.
    Valero T; Steele S; Neumüller K; Bracher A; Niederleithner H; Pehamberger H; Petzelbauer P; Loewe R
    J Invest Dermatol; 2010 Apr; 130(4):1087-94. PubMed ID: 19940857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.
    Zhou P; Qin J; Li Y; Li G; Wang Y; Zhang N; Chen P; Li C
    J Exp Clin Cancer Res; 2017 Sep; 36(1):115. PubMed ID: 28865485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
    Ding B; Zhang W; Wu X; Wang J; Xie C; Huang X; Zhan S; Zheng Y; Huang Y; Xu N; Ding X; Gao S
    Oncotarget; 2016 Aug; 7(35):57160-57170. PubMed ID: 27494835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
    Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
    BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma.
    Hillner BE; Agarwala S; Middleton MR
    J Clin Oncol; 2000 Apr; 18(7):1474-80. PubMed ID: 10735895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
    Biteghe FN; Davids LM
    J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
    Yang C; Cao H; Liu N; Xu K; Ding M; Mao LJ
    Drug Des Devel Ther; 2016; 10():3755-3761. PubMed ID: 27895465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma].
    Levy A; Guitera P; Kerob D; Ollivaud L; Archimbaud A; Dubertret L; Basset-Seguin N
    Ann Dermatol Venereol; 2006 Feb; 133(2):157-60. PubMed ID: 16508601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
    Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
    Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.
    Hervieu A; Rébé C; Végran F; Chalmin F; Bruchard M; Vabres P; Apetoh L; Ghiringhelli F; Mignot G
    J Invest Dermatol; 2013 Feb; 133(2):499-508. PubMed ID: 22951720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
    Bolling R; Meyer-Hamme S; Schauder S
    Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.